AI in healthcare market reaches $2.57 trillion, VentriPoint Diagnostics poised for growth.

The global AI medical imaging market reached $2.57 trillion in 2026, while the AI drug discovery sector reached $1.81 billion. This growth is driven by the adoption of AI-native diagnostic precision and autonomous operations. Companies such as VentriPoint Diagnostics, Recursion Pharmaceuticals, Tempus AI, Schrodinger, and Eli Lilly are benefiting from this trend as they bridge the gap between old-school hardware and high-fidelity digital control. The healthcare industry is expected to reach a projected $132.32 billion in 2026, fueled by the need for real-time data analysis.